OpenLegislation

Regulation 8 Amendment of Schedule 5 to the PMS Agreements Regulations

Original text. Later amendments are not shown.

(1)

Schedule 5 (other contractual terms) to the PMS Agreements Regulations shall be amended as provided in the following paragraphs.

(2)

After paragraph 2 (premises), insert—

“Telephone services

2A.
(1)

The contractor shall not be a party to any contract or other arrangement under which the number for telephone services to be used by—

(a)

patients to contact the practice for any purpose related to the agreement; or

(b)

any other person to contact the practice in relation to services provided as part of the health service,

starts with the digits 087, 090 or 091 or consists of a personal number, unless the service is provided free to the caller.

(2)

In this paragraph, “personal number” means a telephone number which starts with the number 070 followed by a further 8 digits.”.

(3)

After paragraph 9 (standards for out of hours services), insert—

“Supply of medicines etc. by contractors providing out of hours services

9A.
(1)

In this paragraph—

  • “the Charges Regulations” means the National Health Service (Charges for Drugs and Appliances) Regulations 2000f1;

  • “complete course” means the course of treatment appropriate to the patient’s condition, being the same as the amount that would have been prescribed if the patient had been seen during core hours;

  • “necessary drugs, medicines and appliances” means those drugs, medicines and appliances which the patient requires and for which, in the reasonable opinion of the contractor, and in the light of the patient’s medical condition, it would not be reasonable in all the circumstances for the patient to wait until such time as he could obtain them during core hours;

  • “out of hours performer” means a prescriber, a person acting in accordance with a Patient Group Direction or any other health care professional employed or engaged by the contractor who can lawfully supply a drug, medicine or appliance, who is performing out of hours services under the agreement;

  • “Patient Group Direction” has the same meaning as in the Prescription Only Medicines (Human Use) Order 1997f2; and

  • “supply form” means a form provided by a Primary Care Trust and completed by or on behalf of the contractor for the purpose of recording the provision of drugs, medicines or appliances to a patient during the out of hours period.

(2)

Where a contractor whose agreement includes the provision of out of hours services has agreed with the relevant body that its agreement should also include the supply of necessary drugs, medicines and appliances to patients at the time that it is providing them with out of hours services, the contractor shall comply with the requirements in sub-paragraphs (3) to (5).

(3)

The contractor shall ensure that an out of hours performer—

(a)

only supplies necessary drugs, medicines and appliances;

(b)

supplies the complete course of the necessary medicine or drug required to treat the patient; and

(c)

does not supply—

(i)

drugs, medicines or appliances which he could not lawfully supply,

(ii)

appliances which are not listed in Part IX of the Drug Tariff,

(iii)

restricted availability appliances, except where the patient is a person, or it is for a purpose, specified in the Drug Tariff, or

(iv)

a drug, medicine or other substance listed in Schedule 1 to the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc) Regulations 2004f3, or a drug, medicine or other substance listed in Schedule 2 to those Regulations other than in the circumstances specified in that Schedule.

(4)

The out of hours performer shall record on a separate supply form for each patient any drugs, medicines or appliances supplied to the patient provided that a single supply form may be completed where the out of hours performer supplies necessary drugs, medicines or appliances to two or more persons in a school or other institution in which at least 20 persons normally reside, when the out of hours performer may write on the supply form the name of the school or institution rather than the name of the individual patient.

(5)

The out of hours performer shall—

(a)

ask any person who makes a declaration that the patient does not have to pay the charges specified in regulation 4(1) of the Charges Regulationsf4 by virtue of either—

(i)

entitlement to exemption under regulation 7(1) of the Charges Regulationsf5, or

(ii)

entitlement to remission of charges under regulation 5 of the National Health Service (Travel Expenses and Remission of Charges) Regulations 2003f6,

to produce satisfactory evidence of such entitlement, unless the declaration is in respect of entitlement to exemption by virtue of sub-paragraph (a), (c), (d), (e), (f) or (g) of regulation 7(1) of the Charges Regulations, and at the time of the declaration the out of hours performer already has such evidence available to him; and

(b)

if no satisfactory evidence is produced to him (and, where it is relevant, none is already available to him as mentioned in paragraph (a)), endorse the supply form to that effect.

(6)

Subject to sub-paragraph (7), nothing in this paragraph shall prevent an out of hours performer supplying a Scheduled drug or a restricted availability appliance in the course of treating a patient under a private arrangement.

(7)

The provisions of regulation 15 (fees and charges) apply in respect of the supply of necessary drugs, medicines and appliances under this paragraph as they apply in respect of prescriptions for drugs, medicines and appliances.”.

(4)

In paragraph 37 (prescribing)—

(a)

after “issued” insert “or created”; and

(b)

after “paragraphs 38” insert “, 38A”.

(5)

In paragraph 38—

(a)

in sub-paragraph (1), for the words from “by issuing to that patient” to the end substitute—

“by—

(a)

issuing to that patient a non-electronic prescription form or non-electronic repeatable prescription completed in accordance with sub-paragraph (3); or

(b)

where paragraph 38A(1) applies, creating and transmitting an electronic prescription,

and such a non-electronic prescription form, non-electronic repeatable prescription or electronic prescription shall not be used in any other circumstances.”;

(b)

in sub-paragraph (3)—

(i)

for “such” substitute “non-electronic”,

(ii)

before “repeatable prescription”, in the first place that it occurs, insert “non-electronic”, and

(iii)

omit from the words “and—” to the end;

(c)

after sub-paragraph (3), insert—

“(3A)

A prescription form or repeatable prescription shall not refer to any previous prescription form or repeatable prescription.

(3B)

A separate prescription form or repeatable prescription shall be used for each patient, except where a bulk prescription is issued for a school or institution under paragraph 43.”.

(d)

in sub-paragraph (4)—

(i)

after “buprenorphine” insert “or diazepam”, and

(ii)

in paragraph (a), before “prescription form” insert “non-electronic”;

(e)

in sub-paragraph (5), before “prescription form” insert “non-electronic”; and

(f)

in sub-paragraphs (6) and (7)—

(i)

after “issued” insert “or created”, and

(ii)

for paragraph (c), substitute—

“(c)

he undertakes to—

(i)

furnish the chemist within 72 hours with a non-electronic prescription form or non-electronic repeatable prescription completed in accordance with sub-paragraph (3), or

(ii)

transmit to the ETP service within 72 hours an electronic prescription.”.

(6)

After paragraph 38 insert—

“Electronic prescriptions

38A.
(1)

A prescriber may only order drugs, medicines or appliances by means of an electronic prescription if—

(a)

the contractor holds an agreement with a Primary Care Trust which is specified in directions issued by the Secretary of State under section 17 of the Act as being a Primary Care Trust which can authorise its contractors to use the ETP servicef7;

(b)

the patient to whom the prescription relates has—

(i)

nominated one or more dispensers in his NHS Care Record,

(ii)

confirmed that he intends to use that dispenser (or one of them) for the purposes of obtaining the drugs, medicines or appliances ordered on the electronic prescription in question, and

(iii)

consents to the use of an electronic prescription on the particular occasion; and

(c)

the prescription is not—

(i)

for a controlled drug within the meaning of the Misuse of Drugs Act 1971f8, other than a drug which is for the time being specified in Schedule 4 or 5 to the Misuse of Drugs Regulations 2001f9,

(ii)

for supply by instalments under paragraph 38(4), or

(iii)

a bulk prescription issued for a school or institution under paragraph 43.

(2)

In relation to a patient who is a child or an adult incapable of nominating a dispenser, sub-paragraph (1)(b) shall apply as if the reference to the patient to whom the prescription relates included a reference to—

(a)

in the case of a child, that patient’s parent or other person referred to in paragraph 14(4)(a); or

(b)

in the case of an adult, that patient’s relative or primary carer.

(3)

A prescriber who orders drugs, medicines or appliances by means of an electronic prescription shall—

(a)

in the case of an electronic repeatable prescription, issue the patient with a form provided by the Primary Care Trust for the purpose of recording details of that electronic repeatable prescription and linked to that electronic repeatable prescription by a number contained on the form; and

(b)

in the case of an electronic prescription form, issue the patient, if he so requests, with a written record of the prescription which has been created.

Nomination of dispensers for the purpose of electronic prescriptions

38B.
(1)

A contractor which operates the ETP service for its patients shall, if requested to do so by a patient, enter in that patient’s NHS Care Record—

(a)

where he does not have a nominated dispenser, the dispenser chosen by that patient; and

(b)

where he does have a nominated dispenser—

(i)

a replacement dispenser, or

(ii)

a further dispenser,

chosen by that patient.

(2)

Sub-paragraph (1)(b)(ii) shall not apply if the number of nominated dispensers would thereby exceed the maximum number permitted by the ETP service.

(3)

Paragraph 14(4) shall apply in relation to requests under sub-paragraph (1) as it applies to applications for inclusion in a list of patients.

(4)

A contractor—

(a)

shall not seek to persuade a patient to nominate a dispenser recommended by the prescriber or the contractor; and

(b)

shall, if asked by the patient to recommend a chemist whom he might nominate as his dispenser, provide the patient with the list of all the chemists in the area who provide an ETP service as given to the contractor by the Primary Care Trust.”.

(7)

In paragraph 39 (repeatable prescribing services)—

(a)

in sub-paragraph (2)—

(i)

omit paragraphs (a) and (b), and

(ii)

in paragraph (c), before “repeatable prescriptions” insert “non-electronic”; and

(b)

in sub-paragraph (7)(b), for “regulation 20” substitute “regulation 60”.

(8)

In paragraph 40 (repeatable prescriptions)—

(a)

in sub-paragraph (1), before “repeatable prescription” insert “non-electronic”; and

(b)

for sub-paragraphs (2) to (4) substitute—

“(2)

Where a prescriber wishes to make any change to the type, quantity, strength or dosage of drugs, medicines or appliances ordered on a person’s repeatable prescription he must—

(a)

in the case of a non-electronic repeatable prescription—

(i)

notify the person, and

(ii)

make reasonable efforts to notify the chemist providing repeat dispensing services to that person,

that the original repeatable prescription should no longer be used to obtain or provide repeat dispensing services and make arrangements for a replacement repeatable prescription to be issued to that person; or

(b)

in the case of an electronic repeatable prescription—

(i)

arrange with the ETP service for the cancellation of the original repeatable prescription in the person’s NHS Care Record, and

(ii)

create a replacement electronic repeatable prescription relating to that person and notify him that he has done so.

(3)

A prescriber who has created an electronic repeatable prescription for a person must as soon as practicable arrange with the ETP service for its cancellation in that person’s NHS Care Record if, before the expiry of that prescription—

(a)

he considers that it is no longer appropriate or safe for that person to receive the drugs, medicines or appliances ordered on his electronic repeatable prescription or no longer appropriate or safe for him to continue to receive repeatable prescribing services;

(b)

he has issued the person with a non-electronic repeatable prescription in place of the electronic repeatable prescription; or

(c)

it comes to his notice that that person has been removed from the list of patients of the contractor on whose behalf the prescription was issued.

(4)

Where a prescriber has cancelled a person’s electronic repeatable prescription in accordance with sub-paragraph (3) he must, as soon as is practicable, notify that person.

(5)

A prescriber who has issued a non-electronic repeatable prescription in respect of a person must, as soon as practicable, make reasonable efforts to notify the chemist that that repeatable prescription should no longer be used to provide repeat dispensing services to that person, if, before the expiry of that repeatable prescription—

(a)

he considers that it is no longer appropriate or safe for that person to receive the drugs, medicines or appliances ordered on his repeatable prescription or no longer appropriate or safe for him to continue to receive repeatable prescribing services;

(b)

he issues or creates a further repeatable prescription in respect of the person to replace the original repeatable prescription other than in the circumstances referred to in sub-paragraph (2)(a) (for example, because the person wishes to obtain the drugs, medicines or appliances from a different chemist); or

(c)

it comes to his notice that that person has been removed from the list of patients of the contractor on whose behalf the prescription was issued.

(6)

Where the circumstances in sub-paragraph (5)(a) to (c) apply, the prescriber must as soon as practicable notify the person on whose behalf the non-electronic repeatable prescription was issued that that repeatable prescription should no longer be used to obtain repeat dispensing services.”.

(9)

In paragraph 41 (restrictions on prescribing by medical practitioners)—

(a)

in sub-paragraph (2)(c), for “endorses the form with” substitute “includes on the prescription form”; and

(b)

in sub-paragraph (3)(b), for “endorses the face of the form with” substitute “includes on the prescription form”.

(10)

In paragraph 42 (restrictions on prescribing by supplementary prescribers)—

(a)

in sub-paragraph (1)(a), for “give” substitute “issue or create”;

(b)

omit sub-paragraphs (2)(b), (4)(c) and (f) and (6);

(c)

in sub-paragraph (2)(d)(iii), for “giving a prescription, he endorses the face of the form with” substitute “issuing or creating a prescription, he includes on the prescription form”;

(d)

in sub-paragraph (3), for “give” substitute “issue or create”; and

(e)

in sub-paragraph (4), in paragraphs (e)(iii) and (h)(iii), for “giving the prescription, he endorses the face of the form with” substitute “issuing or creating the prescription, he includes on the prescription form”.

(11)

In paragraph 43 (bulk prescribing), in sub-paragraphs (1) and (2), before “prescription form” insert “non-electronic”.

(12)

In paragraph 46 (provision of dispensing services by contractors other than Primary Care Trusts)—

(a)

in sub-paragraph (1), for “regulation 20” substitute “regulation 60”;

(b)

in sub-paragraphs (4)(b) and (9)(a), for “regulation 12(15) or 13(13) of the Pharmaceutical Regulations as they apply pursuant to paragraph 47(5) or (6)” substitute “regulation 20(2) or 38(14)(b) of the Pharmaceutical Regulations as they apply pursuant to paragraph 47(5)”; and

(c)

in sub-paragraph (9)(b)(ii), for “regulation 9(10)” substitute “regulation 31(9)”.

(13)

In paragraph 47 (consent to dispense)—

(a)

in sub-paragraph (2), for “by the Primary Care Trust in accordance with regulations 12 and 13 of the Pharmaceutical Regulations (as modified in accordance with sub-paragraphs (5) and (6)), as though it were an application under regulation 21 of those Regulations” substitute “in accordance with regulations 18, 33, 34 and 36 to 38 of the Pharmaceutical Regulations (as modified in accordance with sub-paragraph (5)), as though it were an application for outline consent under regulation 61 of those Regulations”;

(b)

in sub-paragraph (4), for “regulation 12(16)” substitute “regulation 39(12)”; and

(c)

for sub-paragraphs (5) and (6) substitute—

“(5)

Regulations 18, 20(2), 33, 34, 36 and 38 of the Pharmaceutical Regulations shall apply as if—

(a)

in regulations 18(2), 33(2) and (3) and 36(1), (3) and (9), the references to provisions being “subject to regulations 25 and 26” were omitted;

(b)

in regulations 18(2)(b) and (c), 33(2)(j) and 34(1)(a), for the references to “regulation 61” there were substituted references to this paragraph;

(c)

in regulations 20(2) and 38(2)(c), for the references to “regulation 60” there were substituted references to paragraph 46; and

(d)

in regulation 38(14)(b), for the reference to “arrangements under regulation 60 for the provision by a doctor of pharmaceutical services” there were substituted a reference to arrangements under paragraph 46 for the provision by a contractor of dispensing services.”.

(14)

In paragraph 50 (terms relating to the provision of dispensing services)—

(a)

in sub-paragraph (2)(a), for “on a prescription form completed in accordance with paragraph 38(3);” substitute—

“on—

(i)

a non-electronic prescription form completed in accordance with paragraph 38(3), or

(ii)

if the contractor is the patient’s nominated dispenser (or one of them), an electronic prescription form;”;

(b)

for sub-paragraph (4), substitute—

“(4)

Where a patient—

(a)

presents to a contractor who may provide dispensing services an order on a non-electronic prescription form for drugs, medicines or appliances signed by an independent nurse prescriber, or an order for a restricted availability appliance signed by and endorsed with the reference “SLS” by an independent nurse prescriber; or

(b)

informs a contractor who may provide dispensing services and who is his nominated dispenser (or one of them) that an independent nurse prescriber has ordered drugs, medicines or appliances for him by means of an electronic prescription form,

the contractor may, provided, in a case to which paragraph (b) applies, it has received the electronic prescription form from the ETP service, provide to the patient such of the drugs, medicines or appliances so ordered as it supplies in the normal course of its practice.”; and

(c)

for sub-paragraph (8), substitute—

“(8)

A contractor providing dispensing services shall comply with paragraph 5 of Schedule 2 (terms of service of dispensing doctors) to the Pharmaceutical Regulations, as if modified as follows—

(a)

for “paragraph 3, or in the circumstances set out in paragraph 4” there were substituted “paragraph 50(2) or (4) of Schedule 5 to the PMS Regulations”; and

(b)

for “the dispensing doctor”, in each place where it occurs, there were substituted “the contractor providing dispensing services”.”.

(15)

In paragraph 68 (appraisal and assessment), in sub-paragraph (1)(b), for “NCAA” substitute “NPSA”.

(16)

In paragraph 75 (inquiries about prescriptions and referrals), in sub-paragraph (1)(a), after “issued” insert “or created”.

(17)

In paragraph 76 (reports to a medical officer), in sub-paragraph (1)(b), after “issued” insert “or created”.

(18)

In paragraph 78 (notifications to the relevant body), in sub-paragraph (b), omit “103,”.

(19)

In paragraph 80 (notice provisions specific to an agreement with a qualifying body)—

(a)

in sub-paragraph (1), after paragraph (a) insert—

“(aa)

a new director or secretary is appointed;”;

(b)

in sub-paragraph (2)(a), for “(d) and (f)” substitute “(d) or (f)”; and

(c)

after sub-paragraph (2), insert—

“(3)

A notice under sub-paragraph (1)(aa) shall confirm that the new director or, as the case may be, secretary meets the conditions imposed on directors and secretaries by virtue of regulation 5.”.

(20)

After paragraph 99 (termination by agreement), insert—

“Termination on death

99A.
(1)

Where the agreement is with a single individual and that individual dies, the agreement shall terminate at the end of the period of seven days after the date of his death unless, before the end of that period the Primary Care Trust has agreed in writing with the contractor’s personal representatives that the agreement should continue for a further period, not exceeding 28 days after the end of the period of seven days.

(2)

Sub-paragraph (1) does not affect any other rights to terminate the agreement which the Primary Care Trust may have under paragraphs 104 to 107.”.

(21)

In paragraph 104 (termination by the relevant body for the provision of untrue etc information) for the words “by the contractor before the agreement” to the end substitute —

“by the contractor—

(a)

before the agreement was entered into; or

(b)

pursuant to paragraph 80(2) or (3),

in relation to the conditions set out in regulation 5 (and compliance with those conditions) was, when given, untrue or inaccurate in a material respect.”.

(22)

In paragraph 105 (termination by the relevant body on fitness grounds), in sub-paragraph (1) after “the existence of the agreement” insert “or, if later, on or after the date on which a notice in respect of his compliance with the conditions in regulation 5 was given under paragraph 80(2) or (3)”.

(23)

In paragraph 107 (termination by the relevant body: remedial notices and breach notices), in sub-paragraphs (1) and (5), for “paragraphs 103 to 106” substitute “paragraphs 104 to 106”.

(24)

In paragraph 114 (insurance)—

(a)

renumber the existing provision as sub-paragraph (1); and

(b)

after that provision, insert—

“(2)

In this paragraph, “insurance” has the same meaning as in paragraph 113.”.

Annotations

Footnotes

f1

S.I. 2000/620.

f2

S.I. 1997/1830; relevant amending instruments are S.I. 2000/1917 and 2003/2915.

f3

S.I. 2004/629 as amended by S.I. 2004/3215.

f4

Regulation 4(1) was amended by S.I. 2002/548 and 2004/663.

f5

Regulation 7(1) was amended by S.I. 2000/3189 and 2002/2352.

f6

S.I. 2003/2382 as amended by S.I. 2004/663 and 936.

f7

These directions will be available on the website of the National Programme for IT (www.npfit.nhs.co.uk) and published in the Drug Tariff.

f8

1971 c. 38. The relevant definition is in section 2 and Schedule 2 as amended by S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230, 1989/1340, 1990/2589, 1995/1966, 1996/1300, 1998/750, 2001/3932 and 2003/1243 and 3201.

f9

S.I. 2001/3998; Schedule 4 was amended by S.I. 2003/1432.